US Patent Number
9,724,337
Publication Date
8-8-2017
Abstract
Compositions, methods, and combination therapies for the treatment of cancers, including lymphomas, leukemias, melanomas, lung cancer, and metastatic disease, are provided. Specifically, compositions comprising ligands to Pgrmc1 are disclosed for use in treating and inhibiting tumor growth and progression and inhibition of metastases. The compositions and methods using these ligands can be used alone or in combination with other reagents and cancer treatment modalities.
Assignees
University of Kentucky Research Foundation, Lexington, KY (US)
Application Number
12/763,676
Filing Date
04/20/2010
Recommended Citation
Craven, Rolf Joseph, "AG-205 for the Treatment of Breast Cancer" (2017). Pharmacology and Nutritional Sciences Faculty Patents. 52.
https://uknowledge.uky.edu/pharmacol_patents/52
